Evaluation of Medium Cross-linked Polyethylene With and Without Vitamin E for Total Knee Arthroplasty
NCT ID: NCT04618016
Last Updated: 2025-01-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
605 participants
OBSERVATIONAL
2021-03-08
2034-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Polyethylene Wear Particle Analysis of TKA
NCT06426641
Longterm-Evaluation of Vitelene® Against Standard
NCT01713062
Vitamin E-Diffused Highly Cross-Linked Polyethylene Liner
NCT02801019
Total Knee Arthroplasty With Vitamin E Polyethylene
NCT05810285
Comparison of Rotating vs. Fixed Platform of the COLUMBUS Knee Prosthesis
NCT00822640
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
With Vitamin E
UHMWPE with Vitamin E
e.motion Pro (PS and UC) with MXE gliding surface
Without Vitamin E
UHMWPE without Vitamin E
e.motion Pro (PS and UC) with β-PE gliding surface
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
UHMWPE with Vitamin E
e.motion Pro (PS and UC) with MXE gliding surface
UHMWPE without Vitamin E
e.motion Pro (PS and UC) with β-PE gliding surface
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent for participating at the clinical study
* Willingness and mental ability to participate at the long-term follow-up examinations
Exclusion Criteria
* Pregnancy
* High risk patients (ASA class \>3)
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Raylytic GmbH
INDUSTRY
B. Braun Medical France
UNKNOWN
Aesculap AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wolfram Mittelmeier, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Orthopädische Uniklinik Rostock, Direktor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Sud - CHU de Grenoble
Échirolles, Isere, France
CHU Amiens-Picardie
Amiens, , France
Lukas Krankenhaus
Bünde, North Rhine-Westphalia, Germany
Brüderhaus Koblenz
Koblenz, Rhineland-Palatinate, Germany
Park-Klinik Weißensee
Berlin, , Germany
Waldkliniken Eisenberg
Eisenberg, , Germany
Krankenhaus Reinbek, St. Adolf Stift
Reinbek, , Germany
Universitätsklinikum Rostock, Klinik für Orthopädie
Rostock, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Maier K, Selig M, Haddouche A, Haunschild M, Hauschild O, Khalili I, Kirschberg J, Lutter C, Menges M, Mertl P, Niemeier A, Rubens-Duval B, Mittelmeier W. Vitamin E-enriched medium cross-linked polyethylene in total knee arthroplasty (VIKEP): clinical outcome, oxidation profile, and wear analysis in comparison to standard polyethylene-study protocol for a randomized controlled trial. Trials. 2024 Jan 5;25(1):27. doi: 10.1186/s13063-023-07811-1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAG-O-H-1906
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.